Scholarlink

Introduction <p>Dose administration aids (DAAs) support medication taking, yet little is known about how pharmacists perceive DAA benefits and challenges. This study aimed to explore community pharmacists’ preferences for attributes of a DAA service and how these influence their decision to provide this service.</p> Methods <p>A discrete choice experiment (DCE) was conducted to elicit pharmacists’ preferences. Participants completed 12 choice questions, each presenting three alternatives: two DAA services and no DAA service. The questions included seven attributes: patient type, patient control over their medicines, impact on patient medication adherence, staff time, patient co-payment, government reimbursement fee and presence of a cap on government funded DAA services per pharmacy.</p> Results <p>A total of 615 community pharmacists completed the DCE survey. All attributes, except patient type and co-payment, significantly influenced preferences. Pharmacists were more likely to provide a DAA service (compared with no DAA service) when it was associated with higher government funding (pharmacy owners: OR 1.054, 95% CI 1.046–1.063, <i>p</i>&#xa0;&lt;&#xa0;0.001; non-owners: OR 1.041, 95% CI 1.036–1.046, <i>p</i>&#xa0;&lt;&#xa0;0.001). Pharmacists were less likely to provide a DAA service if there was a cap on the number of funded DAA services (OR 0.905, 95% CI 0.862–0.950, <i>p</i>&#xa0;&lt;&#xa0;0.001), or additional staff time was required (OR 0.981, 95% CI 0.976–0.986, <i>p</i>&#xa0;&lt;&#xa0;0.001).</p> Conclusion <p>This DCE identified two key policy-related barriers to pharmacist provision of DAA services: inadequate government reimbursement and caps on the number of funded DAA services. These findings highlight community pharmacists’ preferences and trade-offs, offering valuable guidance to inform future redesign and implementation of more sustainable and equitable DAA services provided via community pharmacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Rakhee Raghunandan,
  • Parisa Aslani,
  • Timothy F. Chen,
  • Sarah Norris,
  • Andrea Torres-Robles,
  • Noriko Sato,
  • Kirsten Howard

摘要

Introduction

Dose administration aids (DAAs) support medication taking, yet little is known about how pharmacists perceive DAA benefits and challenges. This study aimed to explore community pharmacists’ preferences for attributes of a DAA service and how these influence their decision to provide this service.

Methods

A discrete choice experiment (DCE) was conducted to elicit pharmacists’ preferences. Participants completed 12 choice questions, each presenting three alternatives: two DAA services and no DAA service. The questions included seven attributes: patient type, patient control over their medicines, impact on patient medication adherence, staff time, patient co-payment, government reimbursement fee and presence of a cap on government funded DAA services per pharmacy.

Results

A total of 615 community pharmacists completed the DCE survey. All attributes, except patient type and co-payment, significantly influenced preferences. Pharmacists were more likely to provide a DAA service (compared with no DAA service) when it was associated with higher government funding (pharmacy owners: OR 1.054, 95% CI 1.046–1.063, p < 0.001; non-owners: OR 1.041, 95% CI 1.036–1.046, p < 0.001). Pharmacists were less likely to provide a DAA service if there was a cap on the number of funded DAA services (OR 0.905, 95% CI 0.862–0.950, p < 0.001), or additional staff time was required (OR 0.981, 95% CI 0.976–0.986, p < 0.001).

Conclusion

This DCE identified two key policy-related barriers to pharmacist provision of DAA services: inadequate government reimbursement and caps on the number of funded DAA services. These findings highlight community pharmacists’ preferences and trade-offs, offering valuable guidance to inform future redesign and implementation of more sustainable and equitable DAA services provided via community pharmacy.